PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
28-Oct-2024 ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement ProQR
28-Oct-2024 Aston Institute for Membrane Excellence holds business showcase with Arup and Bruntwood SciTech in Birmingham Tech Week Aston Institute for Membrane Excellence
28-Oct-2024 Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance Sanofi
28-Oct-2024 Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion Corporation
28-Oct-2024 Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Regeneron
28-Oct-2024 England's Health Ombudsman comments on the CQC's State of Care report PHSO
28-Oct-2024 iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress iTeos Therapeutics, Inc
28-Oct-2024 NEW RESEARCH REVEALS LACK OF AWARENESS AROUND ELIGIBILITY FOR WINTER VACCINES Moderna
28-Oct-2024 Travel, work and medical anxiety: The main reasons why millions are missing hospital appointments, costing the NHS £960m a year DrDoctor
28-Oct-2024 Duhn Therapeutics, launched by Landmark BioVentures, signs global license agreement with OM Pharma to further advance clinical-stage, lipid-based cancer immunotherapy Duhn Therapeutics
28-Oct-2024 2nd Global Summit on Vaccines and Immunology(GSVI2025) Apex Global Meetings
28-Oct-2024 HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD's The Liver Meeting 2024 HighTide Therapeutics Inc.
25-Oct-2024 DDI programme ‘ to be wholeheartedly congratulated on staggering multimillion-pound performance’ says InnoScot Health InnoScot Health
25-Oct-2024 InnoScot Health webinar shares ‘spinout success stories’ and the vital support required to get there  InnoScot Health
25-Oct-2024 Atrial Fibrillation Device Market Revolution: How Awareness and Tech Are Transforming Care Pristine Market Insights
25-Oct-2024 Success Stories: Graduates of Clinical Research Courses with 100% Placement Fusion Technology Solutions
23-Oct-2024 New genetic screening programme should be extended to test for untreatable conditions, says leading biotech SynaptixBio
23-Oct-2024 ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares ProQR Therapeutics
23-Oct-2024 Capital Markets Event 2024: Lundbeck to showcase progress on Focused Innovator Strategy driving sustainable long-term growth H. Lundbeck A/S
23-Oct-2024 DARZALEX® (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible Janssen-Cilag International NV